Cannabis‐related deficits in real‐world memory
Catharine Montgomery, Alexandra L. Seddon, John E. Fisk, Philip N. Murphy, Ashok S. Jansari
Human Psychopharmacology: Clinical and Experimental March 1, 2012 DOI: 10.1002/hup.1273 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational case-control study Peer reviewed |
|---|---|
| Sample size | 40 |
| Population | Cannabis-only users and non-illicit drug users |
| Topics | Cannabis |
| Citations | 56 |
| Key findings | Cannabis users performed worse than non-illicit drug users on a virtual reality task of prospective memory and executive function, with deficits on planning, time-based prospective memory, and event-based prospective memory. Indices of cannabis use (length, dose, frequency, total use) correlated with performance on these three subscales. The authors conclude this supports cannabis-related deficits in prospective memory and executive functioning. |
Abstract
Background: Research shows that cannabis users exhibit deficits in prospective memory (PM) and executive function, which persist beyond acute intoxication. However, many studies rely on self-reports of memory failures or use laboratory-based measures that may not mimic functional deficits in the real world. The present study aimed to assess real-world memory functioning.
Method: Twenty cannabis-only users and 20 non-illicit drug users were recruited. Participants completed a substance use inventory and a mood scale, followed by a non-immersive virtual reality task assessing PM and executive functioning. The task involved the participant playing the role of an office worker for the day and performing routine office duties. A number of subscales were used to assess facets of executive function (planning, adaptive thinking, creative thinking, selection, prioritisation) and PM (time-based, event-based and action-based PM).
Results: Multivariate analysis of variance revealed cannabis users performed worse overall on the task, with poor performance on the planning, time-based PM and event-based PM subscales. In addition, indices of cannabis (length, dose, frequency, total use) were correlated with performance on these three subscales.
Conclusions: The present study expands on previously established research, providing support for the cannabis-related deficits in PM and executive functioning, and the role of different aspects of cannabis use in these deficits.
Comparable studies
Other observational and cohort studies on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population | 2009 | Case-control study | n = 454 |
| Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population | 2013 | Observational study | |
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people | 2000 | Observational | |
| Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline | 2011 | Observational cohort | n = 1,923 |
| Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... | 2005 | Observational cohort | n = 535 |
Citations in the library
Cited by 2
Cites 7
- Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users Psychopharmacology October 30, 2010
- Subjective ratings of prospective memory deficits in MDMA (‘ecstasy’) users Human Psychopharmacology: Clinical and Experimental May 9, 2001
- Medial temporal structures and memory functions in adolescents with heavy cannabis use Journal of Psychiatric Research February 5, 2011
- The relationship between non‐acute adolescent cannabis use and cognition Drug and Alcohol Review May 1, 2007
- Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. Synapse July 2003
and 2 more in the library